Come up with a name for your new list and we'll add to it:
CASI Pharmaceuticals raised a round of funding on , . Investors include
Kleiner Perkins Caufield & Byers.
CASI Pharmaceuticals, formerly EntreMed, is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medi…